Investigation Overview
An investigation on behalf of investors of Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares over potential securities laws violations by Halozyme Therapeutics, Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Halozyme The...
You must register (for free) or login to view the entire investigation.